Centessa Pharmaceuticals (CNTA) Debt Ratio (2020 - 2026)

Centessa Pharmaceuticals (CNTA) has 7 years of Debt Ratio data on file, last reported at 0.17 in Q1 2026.

• Quarterly Debt Ratio fell 16.86% year-over-year to 0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.17 (down 16.86% YoY) and the FY2025 annual result came in at 0.16, down 15.21% from the prior year.
• Debt Ratio rose to 0.17 in Q1 2026 per CNTA's latest filing, from 0.16 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.24 in Q3 2025 and bottomed at 0.12 in Q3 2024.
• The 5-year median for Debt Ratio is 0.19 (2023), against an average of 0.18.
• The widest annual swing landed in 2024, when Debt Ratio plunged 36.69%; it then jumped 97.3% in 2025.
• Tracing CNTA's Debt Ratio over 5 years: stood at 0.16 in 2022, then soared by 33.76% to 0.21 in 2023, then slipped by 10.12% to 0.19 in 2024, then retreated by 15.21% to 0.16 in 2025, then increased by 7.46% to 0.17 in 2026.
• Per Business Quant, the three latest CNTA Debt Ratio figures stand at 0.17 (Q1 2026), 0.16 (Q4 2025), and 0.24 (Q3 2025).

Peer Comparison